Deepen your understanding and improve communication with patients and colleagues
New from 2020: The world of cancer treatment is changing rapidly, so the course now includes more content on immunotherapies, including checkpoint inhibitors, CAR T cells, PARP inhibitors and CDK inhibitors.
If you join the course during the first five weeks of it opening, you’ll have the opportunity to engage with its lead educators and mentors when they will be online to answer questions and support your learning. They’ll join the course during the following times in 2021, and we’ll let you more dates as they become available:
- 8 February–12 March
- 10 May–11 June
- 9 August–10 September
Although the course is open to all, it has been designed primarily for clinical research nurses working with patients on clinical cancer trials, along with clinical cancer research staff and specialist cancer nurses. See more information below.
Thanks to ground-breaking research over the past 20 years, new, more targeted treatments and immunotherapies have been developed that are changing the way we treat cancer, and providing new hope for patients. Join us and discover the science behind these treatments and learn through quizzes, interviews, articles and patient case studies. Each week you’ll have the opportunity to engage in discussion with other learners on key issues. You’ll learn from experts in the field and gain a deeper understanding of how targeted cancer treatments and immunotherapies work to support your patients.
This course has been designed primarily for cancer clinical research nurses, along with other members of the cancer clinical research delivery team. It can go towards your Continuing Professional Development (CPD) and/or revalidation with the Nursing and Midwifery Council.
The course is also relevant for and may be of interest to specialist cancer nurses and other health professionals including pharmacists and medical/science graduates studying this topic.
A basic understanding of how cells work is needed to get the most out of this course. Some experience working in cancer is also recommended.